Skip to main content
Log in

Use of 6-Mercaptopurine in Patients with Inflammatory Bowel Disease Previously Intolerant of Azathioprine

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Both azathioprine and its active metabolite, 6-mercaptopurine, are of benefit in the treatment of inflammatory bowel disease, either in resistant cases, or for their steroid-sparing effect. Azathioprine treatment is limited in some patients by hypersensitivity reactions or other side effects. We report our experience in 11 patients previously unable to tolerate azathioprine for a variety of reasons, who were switched to 6-mercaptopurine. Of seven patients with ulcerative colitis and four patients with Crohn's disease who were treated with 6-mercaptopurine following failed azathioprine therapy, six were able to successfully tolerate the substitute medication, with good response. Where patients have previously been intolerant of azathioprine yet ongoing indications for immunosuppressive therapy remain, a trial of 6-mercatopurine may be warranted. Given the similar efficacies of the two drugs in inflammatory bowel disease, these findings also favor the use of 6-mercaptopurine rather than the parent compound as initial therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R: A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 37:674-678, 1995

    Google Scholar 

  2. Present D, Korelitz B, Wisch N, Glass J, Sachar D, Pasternack B: Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 302:981-987, 1980

    Google Scholar 

  3. Pearson D, May G, Fick G, Sutherland L: Azathioprine and 6-mercaptopurine in Crohn Disease. A meta-analysis. Ann Intern Med 122:132-142, 1995

    Google Scholar 

  4. Sandborn W: A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporin, and methotrexate. Am J Gastroenterol 91:423-433, 1996

    Google Scholar 

  5. Present D, Meltzer S, Krumholz M, Wolke A, Korelitz B: 6-Mercaptopurine in the management of inflammatory bowel disease: Short-and long-term toxicity. Ann Intern Med 111:641-649, 1989

    Google Scholar 

  6. Cox J, Daneshmend T, Hawkey C, Logan F, Walt R: Devastating diarrhoea caused by azathioprine: Management difficulty in inflammatory bowel disease. Gut 29:686-688, 1988

    Google Scholar 

  7. Lawson D, Lovatt G, Gurton C, Hennings R: Adverse effects of azathioprine. Adverse Drug React Acute Poisoning Rev 3:161-171, 1984

    Google Scholar 

  8. King J, Laver M, Fairley K: Sensitivity to azathioprine. Med J Aust 2:939-941, 1972

    Google Scholar 

  9. Davis M, Eddleston A, Williams R: Hypersensitivity and jaundice due to azathioprine. Postgrad Med J 56:274-275, 1980

    Google Scholar 

  10. Mahmoud A, Willoughby J: Azathioprine and 6-mercaptopurine are not necessarily interchangeable in the treatment of Crohn's disease. Gastroenterology 108:A868, 1995

    Google Scholar 

  11. Pratt D, Flavin D, Kaplan M: The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 110:271-274, 1996

    Google Scholar 

  12. Colonna T, Korelitz B: The role of leukopaenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease. Am J Gastroenterol 89:362-366, 1994

    Google Scholar 

  13. Lémann M, Bouhnik Y, Kmieciak-Le Corguille M, Bonnet J, Coffin B, Marteau P, Bitoun A, Messing B, Jian R, Matuchansky C, Modigliani R, Rambaud J: Treatment of Crohn's disease (CD) with 6-mercaptopurine (6-MP) in patients intolerant to azathioprine (AZA). Gastroenterology 112:A1025, 1997

    Google Scholar 

  14. Calne R, Alexander G, Murray J: A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs. Ann NY Acad Sci 99:743-761, 1962

    Google Scholar 

  15. Elion G: The pharmacology of azathioprine. Ann NY Acad Sci 685:400-407, 1993

    Google Scholar 

  16. Dalke A, Kazmers I, Kelly W: Hypoxanthine-guanine phosphoribosyltransferase-independent toxicity of azathioprine in human lymphoblasts. Biochem Pharmacol 33:2692-2695, 1984

    Google Scholar 

  17. Dayton J, Turka L, Thompson C, Mitchell B: Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. Mol Pharmacol 41:671-676, 1992

    Google Scholar 

  18. St Georgiev V: Enzymes of the purine metabolism: inhibition and therapeutic potential. Ann NY Acad Sci 685:207-216, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bowen, D.G., Selby, W.S. Use of 6-Mercaptopurine in Patients with Inflammatory Bowel Disease Previously Intolerant of Azathioprine. Dig Dis Sci 45, 1810–1813 (2000). https://doi.org/10.1023/A:1005569808947

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005569808947

Navigation